APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intercellular Adhesion Molecule 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intercellular Adhesion Molecule 1 Market Outlook and Growth Opportunities 2026

26 December 2025195 pages

Choose your research edition.

Industry ResearchIntercellular Adhesion Molecule 1 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Intercellular Adhesion Molecule 1 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Intercellular Adhesion Molecule 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intercellular Adhesion Molecule 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Intercellular Adhesion Molecule 1 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Intercellular Adhesion Molecule 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intercellular Adhesion Molecule 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intercellular Adhesion Molecule 1 market include RXi Pharmaceuticals Corp, China Medical System Holdings Ltd and Atlantic Healthcare Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intercellular Adhesion Molecule 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intercellular Adhesion Molecule 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intercellular Adhesion Molecule 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intercellular Adhesion Molecule 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Intercellular Adhesion Molecule 1 Segment by Company

RXi Pharmaceuticals Corp

China Medical System Holdings Ltd

Atlantic Healthcare Plc

Intercellular Adhesion Molecule 1 Segment by Type

CMS-024

DNP-003

MS-553

Others

Intercellular Adhesion Molecule 1 Segment by Application

Genito Urinary System and Sex Hormones

Dermatology

Crohn's Disease

Others

Intercellular Adhesion Molecule 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intercellular Adhesion Molecule 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intercellular Adhesion Molecule 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intercellular Adhesion Molecule 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Intercellular Adhesion Molecule 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intercellular Adhesion Molecule 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intercellular Adhesion Molecule 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intercellular Adhesion Molecule 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intercellular Adhesion Molecule 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intercellular Adhesion Molecule 1 industry.

Chapter 3: Detailed analysis of Intercellular Adhesion Molecule 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intercellular Adhesion Molecule 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intercellular Adhesion Molecule 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intercellular Adhesion Molecule 1 Industry Trends Table 2. Intercellular Adhesion Molecule 1 Industry Drivers Table 3. Intercellular Adhesion Molecule 1 Industry Opportunities and Challenges Table 4. Intercellular Adhesion Molecule 1 Industry Restraints Table 5. Global Intercellular Adhesion Molecule 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intercellular Adhesion Molecule 1 Revenue Share by Company (2021-2026) Table 7. Global Intercellular Adhesion Molecule 1 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Company (2021-2026) Table 9. Global Intercellular Adhesion Molecule 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Intercellular Adhesion Molecule 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intercellular Adhesion Molecule 1 Key Company Manufacturing Base & Headquarters Table 12. Global Intercellular Adhesion Molecule 1 Company, Product Type & Application Table 13. Global Intercellular Adhesion Molecule 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intercellular Adhesion Molecule 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CMS-024 Table 18. Significant Companies of DNP-003 Table 19. Significant Companies of MS-553 Table 20. Significant Companies of Others Table 21. Global Intercellular Adhesion Molecule 1 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Intercellular Adhesion Molecule 1 Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Intercellular Adhesion Molecule 1 Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Type (2021-2026) Table 25. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Type (2027-2032) Table 26. Global Intercellular Adhesion Molecule 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Intercellular Adhesion Molecule 1 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Intercellular Adhesion Molecule 1 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Intercellular Adhesion Molecule 1 Sales Value Share by Type (2021-2026) Table 30. Global Intercellular Adhesion Molecule 1 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Genito Urinary System and Sex Hormones Table 32. Significant Companies of Dermatology Table 33. Significant Companies of Crohn's Disease Table 34. Significant Companies of Others Table 35. Global Intercellular Adhesion Molecule 1 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Intercellular Adhesion Molecule 1 Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Intercellular Adhesion Molecule 1 Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Application (2021-2026) Table 39. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Application (2027-2032) Table 40. Global Intercellular Adhesion Molecule 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Intercellular Adhesion Molecule 1 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Intercellular Adhesion Molecule 1 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Intercellular Adhesion Molecule 1 Sales Value Share by Application (2021-2026) Table 44. Global Intercellular Adhesion Molecule 1 Sales Value Share by Application (2027-2032) Table 45. Global Intercellular Adhesion Molecule 1 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Intercellular Adhesion Molecule 1 Sales by Region (2021-2026) & (W Units) Table 47. Global Intercellular Adhesion Molecule 1 Sales Market Share by Region (2021-2026) Table 48. Global Intercellular Adhesion Molecule 1 Sales by Region (2027-2032) & (W Units) Table 49. Global Intercellular Adhesion Molecule 1 Sales Market Share by Region (2027-2032) Table 50. Global Intercellular Adhesion Molecule 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Intercellular Adhesion Molecule 1 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Intercellular Adhesion Molecule 1 Sales Value Share by Region (2021-2026) Table 53. Global Intercellular Adhesion Molecule 1 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Intercellular Adhesion Molecule 1 Sales Value Share by Region (2027-2032) Table 55. Global Intercellular Adhesion Molecule 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Intercellular Adhesion Molecule 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Intercellular Adhesion Molecule 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 60. Global Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 61. Global Intercellular Adhesion Molecule 1 Sales by Country (2027-2032) & (W Units) Table 62. Global Intercellular Adhesion Molecule 1 Sales Market Share by Country (2027-2032) Table 63. Global Intercellular Adhesion Molecule 1 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Intercellular Adhesion Molecule 1 Sales Value Market Share by Country (2021-2026) Table 65. Global Intercellular Adhesion Molecule 1 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Intercellular Adhesion Molecule 1 Sales Value Market Share by Country (2027-2032) Table 67. RXi Pharmaceuticals Corp Company Information Table 68. RXi Pharmaceuticals Corp Business Overview Table 69. RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Product Portfolio Table 71. RXi Pharmaceuticals Corp Recent Development Table 72. China Medical System Holdings Ltd Company Information Table 73. China Medical System Holdings Ltd Business Overview Table 74. China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Product Portfolio Table 76. China Medical System Holdings Ltd Recent Development Table 77. Atlantic Healthcare Plc Company Information Table 78. Atlantic Healthcare Plc Business Overview Table 79. Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Product Portfolio Table 81. Atlantic Healthcare Plc Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Intercellular Adhesion Molecule 1 Distributors List Table 85. Intercellular Adhesion Molecule 1 Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Intercellular Adhesion Molecule 1 Product Image Figure 2. Global Intercellular Adhesion Molecule 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intercellular Adhesion Molecule 1 Sales (2021-2032) & (W Units) Figure 5. Global Intercellular Adhesion Molecule 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Intercellular Adhesion Molecule 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CMS-024 Image Figure 10. DNP-003 Image Figure 11. MS-553 Image Figure 12. Others Image Figure 13. Global Intercellular Adhesion Molecule 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Intercellular Adhesion Molecule 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Type (2021-2032) Figure 16. Global Intercellular Adhesion Molecule 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Intercellular Adhesion Molecule 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Intercellular Adhesion Molecule 1 Sales Value Share by Type (2021-2032) Figure 19. Genito Urinary System and Sex Hormones Image Figure 20. Dermatology Image Figure 21. Crohn's Disease Image Figure 22. Others Image Figure 23. Global Intercellular Adhesion Molecule 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Intercellular Adhesion Molecule 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Intercellular Adhesion Molecule 1 Sales Volume Share by Application (2021-2032) Figure 26. Global Intercellular Adhesion Molecule 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Intercellular Adhesion Molecule 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Intercellular Adhesion Molecule 1 Sales Value Share by Application (2021-2032) Figure 29. Global Intercellular Adhesion Molecule 1 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Intercellular Adhesion Molecule 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Intercellular Adhesion Molecule 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Intercellular Adhesion Molecule 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Intercellular Adhesion Molecule 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Intercellular Adhesion Molecule 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Intercellular Adhesion Molecule 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Intercellular Adhesion Molecule 1 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Intercellular Adhesion Molecule 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Intercellular Adhesion Molecule 1 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Intercellular Adhesion Molecule 1 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • CMS-024
  • DNP-003
  • MS-553
  • Others
Applications
  • Genito Urinary System and Sex Hormones
  • Dermatology
  • Crohn's Disease
  • Others
Companies covered
  • RXi Pharmaceuticals Corp
  • China Medical System Holdings Ltd
  • Atlantic Healthcare Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  4. 1.2.2 Global Intercellular Adhesion Molecule 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Intercellular Adhesion Molecule 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intercellular Adhesion Molecule 1 Market Dynamics
  1. 2.1 Intercellular Adhesion Molecule 1 Industry Trends
  2. 2.2 Intercellular Adhesion Molecule 1 Industry Drivers
  3. 2.3 Intercellular Adhesion Molecule 1 Industry Opportunities and Challenges
  4. 2.4 Intercellular Adhesion Molecule 1 Industry Restraints
3 Intercellular Adhesion Molecule 1 Market by Company
  1. 3.1 Global Intercellular Adhesion Molecule 1 Company Revenue Ranking in 2025
  2. 3.2 Global Intercellular Adhesion Molecule 1 Revenue by Company (2021-2026)
  3. 3.3 Global Intercellular Adhesion Molecule 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Intercellular Adhesion Molecule 1 Average Price by Company (2021-2026)
  5. 3.5 Global Intercellular Adhesion Molecule 1 Company Ranking (2024-2026)
  6. 3.6 Global Intercellular Adhesion Molecule 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Intercellular Adhesion Molecule 1 Company Product Type and Application
  8. 3.8 Global Intercellular Adhesion Molecule 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intercellular Adhesion Molecule 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intercellular Adhesion Molecule 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intercellular Adhesion Molecule 1 Market by Type
  1. 4.1 Intercellular Adhesion Molecule 1 Type Introduction
  2. 4.1.1 CMS-024
  3. 4.1.2 DNP-003
  4. 4.1.3 MS-553
  5. 4.1.4 Others
  6. 4.2 Global Intercellular Adhesion Molecule 1 Sales Volume by Type
  7. 4.2.1 Global Intercellular Adhesion Molecule 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Intercellular Adhesion Molecule 1 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Intercellular Adhesion Molecule 1 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Intercellular Adhesion Molecule 1 Sales Value by Type
  11. 4.3.1 Global Intercellular Adhesion Molecule 1 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Intercellular Adhesion Molecule 1 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Intercellular Adhesion Molecule 1 Sales Value Share by Type (2021-2032)
5 Intercellular Adhesion Molecule 1 Market by Application
  1. 5.1 Intercellular Adhesion Molecule 1 Application Introduction
  2. 5.1.1 Genito Urinary System and Sex Hormones
  3. 5.1.2 Dermatology
  4. 5.1.3 Crohn's Disease
  5. 5.1.4 Others
  6. 5.2 Global Intercellular Adhesion Molecule 1 Sales Volume by Application
  7. 5.2.1 Global Intercellular Adhesion Molecule 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intercellular Adhesion Molecule 1 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Intercellular Adhesion Molecule 1 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Intercellular Adhesion Molecule 1 Sales Value by Application
  11. 5.3.1 Global Intercellular Adhesion Molecule 1 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intercellular Adhesion Molecule 1 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Intercellular Adhesion Molecule 1 Sales Value Share by Application (2021-2032)
6 Intercellular Adhesion Molecule 1 Regional Sales and Value Analysis
  1. 6.1 Global Intercellular Adhesion Molecule 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intercellular Adhesion Molecule 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Intercellular Adhesion Molecule 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Intercellular Adhesion Molecule 1 Sales by Region (2027-2032)
  5. 6.3 Global Intercellular Adhesion Molecule 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intercellular Adhesion Molecule 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intercellular Adhesion Molecule 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intercellular Adhesion Molecule 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Intercellular Adhesion Molecule 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  12. 6.6.2 North America Intercellular Adhesion Molecule 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Intercellular Adhesion Molecule 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  21. 6.9.2 South America Intercellular Adhesion Molecule 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intercellular Adhesion Molecule 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intercellular Adhesion Molecule 1 Sales Value Share by Country, 2025 VS 2032
7 Intercellular Adhesion Molecule 1 Country-level Sales and Value Analysis
  1. 7.1 Global Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intercellular Adhesion Molecule 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intercellular Adhesion Molecule 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Intercellular Adhesion Molecule 1 Sales by Country (2027-2032)
  6. 7.4 Global Intercellular Adhesion Molecule 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intercellular Adhesion Molecule 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intercellular Adhesion Molecule 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intercellular Adhesion Molecule 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intercellular Adhesion Molecule 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intercellular Adhesion Molecule 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RXi Pharmaceuticals Corp
  2. 8.1.1 RXi Pharmaceuticals Corp Company Information
  3. 8.1.2 RXi Pharmaceuticals Corp Business Overview
  4. 8.1.3 RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Product Portfolio
  6. 8.1.5 RXi Pharmaceuticals Corp Recent Developments
  7. 8.2 China Medical System Holdings Ltd
  8. 8.2.1 China Medical System Holdings Ltd Company Information
  9. 8.2.2 China Medical System Holdings Ltd Business Overview
  10. 8.2.3 China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Product Portfolio
  12. 8.2.5 China Medical System Holdings Ltd Recent Developments
  13. 8.3 Atlantic Healthcare Plc
  14. 8.3.1 Atlantic Healthcare Plc Company Information
  15. 8.3.2 Atlantic Healthcare Plc Business Overview
  16. 8.3.3 Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Product Portfolio
  18. 8.3.5 Atlantic Healthcare Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intercellular Adhesion Molecule 1 Value Chain Analysis
  2. 9.1.1 Intercellular Adhesion Molecule 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intercellular Adhesion Molecule 1 Sales Mode & Process
  6. 9.2 Intercellular Adhesion Molecule 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intercellular Adhesion Molecule 1 Distributors
  9. 9.2.3 Intercellular Adhesion Molecule 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst